XML 39 R16.htm IDEA: XBRL DOCUMENT
v3.25.4

INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
INTANGIBLE ASSETS | NOTE 4 - INTANGIBLE ASSETS The Company is a party to a license agreement with the SCTC (as amended) (the “SCTC Agreement”). Pursuant to the SCTC Agreement, the Company obtained, among other things, a worldwide (excluding Asia and Argentina), exclusive, royalty-bearing license from the SCTC to utilize or sublicense a certain method for culturing cells and a worldwide, exclusive, royalty-bearing license from the SCTC to utilize or sublicense a certain medical device patent for the administration of specific cells and/or cell products to the disc and/or spine (and other parts of the body). In February 2017, the Company received authorization from the Food and Drug Administration (the “FDA”) to proceed with a Phase 2 clinical trial. In February 2022, the Company announced that the United States Patent and Trademark Office issued a notice of allowance for a patent application relating to the Company’s BRTX-100 clinical program. This patent was issued in March 2022. Intangible assets consist of the following: SCHEDULE OF INTANGIBLE ASSETS
|  | Patents and Trademarks |  |  | Licenses |  |  | Accumulated Amortization |  |  | Total |
Balance as of January 1, 2023 |  | $ | 3,676 |  |  | $ | 1,593,530 |  |  | $ | (793,768 | ) |  | $ | 803,438 |
Amortization expense |  |  | - |  |  |  | - |  |  |  | (89,746 | ) |  |  | (89,746 | )
Balance as of December 31, 2023 |  |  | 3,676 |  |  |  | 1,593,530 |  |  |  | (883,514 | ) |  |  | 713,692 |
Amortization expense |  |  | - |  |  |  | - |  |  |  | (89,747 | ) |  |  | (89,747 | )
Balance as of December 31, 2024 |  | $ | 3,676 |  |  | $ | 1,593,530 |  |  | $ | (973,261 | ) |  | $ | 623,945 |
Weighted average remaining amortization period at December 31, 2024 (in years) |  |  | - |  |  |  | 10.3 |  |  |  |  |  |  |  |  |
Amortization of intangible assets consists of the following: SCHEDULE OF FINITE LIVED INTANGIBLE ASSETS AMORTIZATION EXPENSES
|  | Patents and Trademarks |  |  | Licenses |  |  | Accumulated Amortization |
Balance as of January 1, 2023 |  | $ | 3,676 |  |  | $ | 790,092 |  |  | $ | 793,768 |
Amortization expense |  |  | - |  |  |  | 89,746 |  |  |  | 89,746 |
Balance as of December 31, 2023 |  |  | 3,676 |  |  |  | 879,838 |  |  |  | 883,514 |
Amortization expense |  |  | - |  |  |  | 89,747 |  |  |  | 89,747 |
Balance as of December 31, 2024 |  | $ | 3,676 |  |  | $ | 969,585 |  |  | $ | 973,261 |
Amortization expense for the next five years is as follows: SCHEDULE OF FINITE LIVED INTANGIBLE ASSETS FUTURE AMORTIZATION EXPENSES
For the Years Ending December 31, |  | Total |
2025 |  | $ | 89,746 |
2026 |  |  | 89,746 |
2027 |  |  | 89,746 |
2028 |  |  | 89,746 |
2029 |  |  | 89,746 |
Total |  | $ | 448,730 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/985-20/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration